Special Edition: Our Continued COVID‑19 CoverageApril 20, 2020 | Oncology Allergy & Immunology COVID-19 and Cancer Consortium (CCC19) Launched Although timely access to the results of studies evaluating patients with cancer infected with COVID-19 is urgently needed, such evidence is currently very limited. The CCC19 hopes to change all of that. Read full article Family Medicine/General Practice Does Clinician/Researcher Bias Contribute to Low Enrollment of Minorities in Cancer Clinical Trials? This study in Cancer suggests the possibility, pointing to qualitative results of clinical trial principal investigators, research staff, referring clinicians, and cancer center leaders regarding their attitudes and experiences with enrolling minority patients in cancer clinical trials. Read full article Allergy & Immunology NCCN Offers Strategies to Prevent the Spread of COVID-19 in Oncology Practices Beyond converting to telehealth platforms and limiting in-office visits, the Best Practices Committee of the NCCN shares essential approaches to help mitigate the transmission of COVID-19 among patients with cancer and the health care workers who treat them. Read full article